S&P 500 Moderna Rebound: Can Biotech Strength Cushion the AI Chip Sell-Off?

S&P 500 Moderna Rebound: Can Biotech Strength Cushion the AI Chip Sell-Off?
STARTS NOW! Rebel's Edge 1pm $NVDA $PANW $MRNA $GRMN 🏈 NAJARIAN SPORTS 🏴☠️ with @petenajarian NCAA: who dominated the portal what schools really dominated the portal, Pete's Top 3 NFL: Free Agency is less than a month Top 5 QBs and possible landing spots #ITSNOTANOPTION 📙 https://t.co/pdCmmm2onX
Moderna got the FDA to change its mind and review its flu vaccine after some concessions
📅IT’S A BIG WEEK OF EARNINGS! 📈 $CSCO $ANET $AMAT $NBIS $HOOD $COIN $DKNG $SHOP $APP $ALAB $DDOG $NET $HUBS $PINS $SPOT $KO $KHC $MCD $WEN $CVS $MRNA $OSCR $F $RIVN $RACE $LYFT $TMUS $BP WILL DELIVER RESULTS! 💰MAKE SMARTER INVESTMENT DECISIONS WITH ‘PRO PICKS AI’: https://t.co/o9NLlYA1jt
21.62BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US60770K1079
CUSIP
60770K107
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
18.66
Dividend Share
-
Dividend Yield
-
Earnings Share
-8.14
Wall Street Target Price
49.37
EPS Estimate Current Year
-8.67
EPS Estimate Next Year
-4.75
EPS Estimate Current Quarter
-3.8799
EPS Estimate Next Quarter
-2.1853
Most Recent Quarter
-
Revenue TTM
2,224,999,936
Gross Profit TTM
-1,555,000,064
EBITDA
-2,299,000,064
Profit Margin
-143.55%
Return On Assets TTM
-13.09%
Return On Equity TTM
-36.56%
Revenue Per Share TTM
5.687
Qtly Revenue Growth YOY
260.20%
Diluted Eps TTM
-8.14
Qtly Earnings Growth YOY
-85.10%
Trailing PE
0.00
Forward PE
23
Price Sales TTM
10.3289
Price Book MRQ
2.9186
Enterprise Value Revenue
8
Enterprise Value EBITDA
4
760.00
3.03%22.75
2.52%865.00
0.00%88.94
0.00%124.85
-12.62%259.59
-12.18%853.82
-2.26%187.48
-2.14%476.99
-0.98%204.11
-0.83%Curated watchlists where MRNA is featured.